This inventor holds 2 USPTO granted patents and 7 published patent applications. Top assignees: Shenzhen Innovation Immunotechnology Co., Ltd., The Methodist Hospital System. Active years: 2020-2026.
Company Filing History:
1 out of 1 
1 out of 20 Years Active: 2020-2026
Title: The Innovative Contributions of Rongfu Wang
Introduction
Rongfu Wang is a notable inventor based in Houston, TX (US), recognized for his significant contributions to the field of cancer immunotherapy. With a total of 2 patents, his work focuses on developing innovative solutions for cancer treatment.
Latest Patents
Wang's latest patents include groundbreaking research on cancer neoantigens and their utilities in cancer vaccines and TCR-based cancer immunotherapy. One of his notable patents involves prostate-specific tumor antigens and their uses. This research examined twenty-one PSGR-derived peptides predicted by an immuno-informatics approach based on the HLA-A2 binding motif. The study assessed their ability to induce peptide-specific T cell responses in peripheral blood mononuclear cells (PBMCs) obtained from both HLA-A2+ healthy donors and HLA-A2+ prostate cancer patients. The recognition of HLA-A2 positive and PSGR expressing LNCaP cells was also tested. Three peptides, PSGR3, PSGR4, and PSGR14, frequently induced peptide-specific T cell responses in PBMCs from both healthy donors and prostate cancer patients. These peptides are recognized by CD8+ T cells in an HLA-A2 dependent manner. The identified PSGR-derived peptides are useful as diagnostic markers and immune targets for anticancer vaccines.
Career Highlights
Throughout his career, Rongfu Wang has worked with prominent organizations, including Shenzhen Innovation Immunotechnology Co., Ltd. and The Methodist Hospital System. His research has significantly advanced the understanding of cancer immunotherapy and has the potential to improve treatment outcomes for patients.
Collaborations
Wang has collaborated with notable colleagues, including Yicheng Wang and Lili Zhang, contributing to the advancement of cancer research and immunotherapy.
Conclusion
Rongfu Wang's innovative work in cancer immunotherapy and his contributions to the field through his patents highlight his role as a leading inventor. His research continues to pave the way for new therapeutic approaches in cancer treatment.